nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonazepam—Tongue coated—Varenicline—nicotine dependence	0.038	0.0623	CcSEcCtD
Clonazepam—Panic reaction—Varenicline—nicotine dependence	0.0257	0.042	CcSEcCtD
Clonazepam—Gingival pain—Varenicline—nicotine dependence	0.0236	0.0386	CcSEcCtD
Clonazepam—Pleurisy—Varenicline—nicotine dependence	0.0211	0.0345	CcSEcCtD
Clonazepam—GABRB2—GABA A receptor activation—GABRA4—nicotine dependence	0.0169	0.0463	CbGpPWpGaD
Clonazepam—GABRA3—GABA A receptor activation—GABRA4—nicotine dependence	0.0161	0.0441	CbGpPWpGaD
Clonazepam—GABRG2—GABA A receptor activation—GABRA4—nicotine dependence	0.0154	0.0423	CbGpPWpGaD
Clonazepam—Anger—Varenicline—nicotine dependence	0.0144	0.0236	CcSEcCtD
Clonazepam—Respiratory tract congestion—Varenicline—nicotine dependence	0.0141	0.0231	CcSEcCtD
Clonazepam—Abnormal behaviour—Varenicline—nicotine dependence	0.0138	0.0226	CcSEcCtD
Clonazepam—GABRA1—GABA A receptor activation—GABRA4—nicotine dependence	0.0135	0.037	CbGpPWpGaD
Clonazepam—Dysphoria—Varenicline—nicotine dependence	0.0119	0.0195	CcSEcCtD
Clonazepam—Hoarseness—Varenicline—nicotine dependence	0.0117	0.0192	CcSEcCtD
Clonazepam—GABRB2—Ligand-gated ion channel transport—GABRA4—nicotine dependence	0.0103	0.0283	CbGpPWpGaD
Clonazepam—CYP2E1—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0103	0.0282	CbGpPWpGaD
Clonazepam—Suicide—Varenicline—nicotine dependence	0.00992	0.0163	CcSEcCtD
Clonazepam—GABRA3—Ligand-gated ion channel transport—GABRA4—nicotine dependence	0.00985	0.027	CbGpPWpGaD
Clonazepam—GABRG2—Ligand-gated ion channel transport—GABRA4—nicotine dependence	0.00944	0.0259	CbGpPWpGaD
Clonazepam—Hostility—Varenicline—nicotine dependence	0.0093	0.0152	CcSEcCtD
Clonazepam—Sleep disturbance—Varenicline—nicotine dependence	0.00918	0.015	CcSEcCtD
Clonazepam—Completed suicide—Varenicline—nicotine dependence	0.00875	0.0143	CcSEcCtD
Clonazepam—Platelet count decreased—Varenicline—nicotine dependence	0.00865	0.0142	CcSEcCtD
Clonazepam—Toothache—Varenicline—nicotine dependence	0.00846	0.0139	CcSEcCtD
Clonazepam—Libido increased—Varenicline—nicotine dependence	0.00846	0.0139	CcSEcCtD
Clonazepam—GABRA1—Ligand-gated ion channel transport—GABRA4—nicotine dependence	0.00825	0.0227	CbGpPWpGaD
Clonazepam—Upset stomach—Varenicline—nicotine dependence	0.00786	0.0129	CcSEcCtD
Clonazepam—Delusion—Varenicline—nicotine dependence	0.00727	0.0119	CcSEcCtD
Clonazepam—Nystagmus—Varenicline—nicotine dependence	0.00721	0.0118	CcSEcCtD
Clonazepam—Menorrhagia—Varenicline—nicotine dependence	0.00695	0.0114	CcSEcCtD
Clonazepam—Scotoma—Varenicline—nicotine dependence	0.00678	0.0111	CcSEcCtD
Clonazepam—Fungal infection—Varenicline—nicotine dependence	0.00667	0.0109	CcSEcCtD
Clonazepam—CYP2E1—Xenobiotics—CYP2A7—nicotine dependence	0.00636	0.0175	CbGpPWpGaD
Clonazepam—Rhinorrhoea—Varenicline—nicotine dependence	0.00635	0.0104	CcSEcCtD
Clonazepam—Dysphonia—Varenicline—nicotine dependence	0.00626	0.0103	CcSEcCtD
Clonazepam—Endocrine disorder—Varenicline—nicotine dependence	0.00621	0.0102	CcSEcCtD
Clonazepam—Eye irritation—Varenicline—nicotine dependence	0.00603	0.00988	CcSEcCtD
Clonazepam—Disturbance in attention—Varenicline—nicotine dependence	0.00594	0.00974	CcSEcCtD
Clonazepam—Aggression—Varenicline—nicotine dependence	0.00586	0.0096	CcSEcCtD
Clonazepam—Viral infection—Varenicline—nicotine dependence	0.0057	0.00934	CcSEcCtD
Clonazepam—NAT2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00569	0.0156	CbGpPWpGaD
Clonazepam—Nocturia—Varenicline—nicotine dependence	0.00555	0.00909	CcSEcCtD
Clonazepam—GABRB2—GABA receptor activation—GABRA4—nicotine dependence	0.00548	0.015	CbGpPWpGaD
Clonazepam—Dysarthria—Varenicline—nicotine dependence	0.00544	0.00892	CcSEcCtD
Clonazepam—NAT2—Biological oxidations—CYP2A7—nicotine dependence	0.00537	0.0147	CbGpPWpGaD
Clonazepam—NAT2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00529	0.0145	CbGpPWpGaD
Clonazepam—Coordination abnormal—Varenicline—nicotine dependence	0.00524	0.00859	CcSEcCtD
Clonazepam—GABRA3—GABA receptor activation—GABRA4—nicotine dependence	0.00523	0.0143	CbGpPWpGaD
Clonazepam—Abnormal dreams—Varenicline—nicotine dependence	0.00509	0.00834	CcSEcCtD
Clonazepam—GABRG2—GABA receptor activation—GABRA4—nicotine dependence	0.00501	0.0137	CbGpPWpGaD
Clonazepam—Salivary hypersecretion—Varenicline—nicotine dependence	0.005	0.00819	CcSEcCtD
Clonazepam—Nightmare—Varenicline—nicotine dependence	0.00497	0.00815	CcSEcCtD
Clonazepam—Urine output increased—Varenicline—nicotine dependence	0.00465	0.00763	CcSEcCtD
Clonazepam—Hypertonia—Varenicline—nicotine dependence	0.00451	0.00739	CcSEcCtD
Clonazepam—Mental disability—Varenicline—nicotine dependence	0.00447	0.00732	CcSEcCtD
Clonazepam—Euphoric mood—Varenicline—nicotine dependence	0.00442	0.00725	CcSEcCtD
Clonazepam—Lymphadenopathy—Varenicline—nicotine dependence	0.00438	0.00718	CcSEcCtD
Clonazepam—GABRA1—GABA receptor activation—GABRA4—nicotine dependence	0.00438	0.012	CbGpPWpGaD
Clonazepam—Sleep disorder—Varenicline—nicotine dependence	0.00432	0.00707	CcSEcCtD
Clonazepam—Polyuria—Varenicline—nicotine dependence	0.00426	0.00697	CcSEcCtD
Clonazepam—Disorientation—Varenicline—nicotine dependence	0.00418	0.00685	CcSEcCtD
Clonazepam—Libido decreased—Varenicline—nicotine dependence	0.00403	0.0066	CcSEcCtD
Clonazepam—Increased appetite—Varenicline—nicotine dependence	0.00398	0.00652	CcSEcCtD
Clonazepam—Amnesia—Varenicline—nicotine dependence	0.00398	0.00652	CcSEcCtD
Clonazepam—Visual disturbance—Varenicline—nicotine dependence	0.00394	0.00646	CcSEcCtD
Clonazepam—Thirst—Varenicline—nicotine dependence	0.00393	0.00643	CcSEcCtD
Clonazepam—Lethargy—Varenicline—nicotine dependence	0.00381	0.00625	CcSEcCtD
Clonazepam—Osteoarthritis—Varenicline—nicotine dependence	0.00374	0.00612	CcSEcCtD
Clonazepam—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.00371	0.00607	CcSEcCtD
Clonazepam—Affect lability—Varenicline—nicotine dependence	0.00368	0.00603	CcSEcCtD
Clonazepam—Migraine—Varenicline—nicotine dependence	0.00368	0.00603	CcSEcCtD
Clonazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.00367	0.0101	CbGpPWpGaD
Clonazepam—Psychotic disorder—Varenicline—nicotine dependence	0.00365	0.00598	CcSEcCtD
Clonazepam—Bromazepam—GABRA4—nicotine dependence	0.00363	0.177	CrCbGaD
Clonazepam—Irritability—Varenicline—nicotine dependence	0.00357	0.00584	CcSEcCtD
Clonazepam—Urinary retention—Varenicline—nicotine dependence	0.00355	0.00582	CcSEcCtD
Clonazepam—Mood swings—Varenicline—nicotine dependence	0.00354	0.0058	CcSEcCtD
Clonazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.00351	0.00962	CbGpPWpGaD
Clonazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.00348	0.00956	CbGpPWpGaD
Clonazepam—Liver function test abnormal—Varenicline—nicotine dependence	0.00345	0.00565	CcSEcCtD
Clonazepam—Breast disorder—Varenicline—nicotine dependence	0.00338	0.00553	CcSEcCtD
Clonazepam—Cramp muscle—Varenicline—nicotine dependence	0.00336	0.00551	CcSEcCtD
Clonazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.00336	0.00922	CbGpPWpGaD
Clonazepam—Nasopharyngitis—Varenicline—nicotine dependence	0.00334	0.00548	CcSEcCtD
Clonazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.00332	0.00912	CbGpPWpGaD
Clonazepam—Gastritis—Varenicline—nicotine dependence	0.00331	0.00542	CcSEcCtD
Clonazepam—Dysphagia—Varenicline—nicotine dependence	0.00323	0.00529	CcSEcCtD
Clonazepam—Asthma—Varenicline—nicotine dependence	0.00323	0.00529	CcSEcCtD
Clonazepam—GABRB2—Orphan transporters—GABRA4—nicotine dependence	0.00319	0.00877	CbGpPWpGaD
Clonazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.00319	0.00874	CbGpPWpGaD
Clonazepam—Bronchitis—Varenicline—nicotine dependence	0.00311	0.00509	CcSEcCtD
Clonazepam—Abdominal discomfort—Varenicline—nicotine dependence	0.0031	0.00507	CcSEcCtD
Clonazepam—GABRA3—Orphan transporters—GABRA4—nicotine dependence	0.00305	0.00836	CbGpPWpGaD
Clonazepam—Pollakiuria—Varenicline—nicotine dependence	0.00298	0.00489	CcSEcCtD
Clonazepam—Erectile dysfunction—Varenicline—nicotine dependence	0.00297	0.00487	CcSEcCtD
Clonazepam—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00295	0.0081	CbGpPWpGaD
Clonazepam—Weight increased—Varenicline—nicotine dependence	0.00294	0.00482	CcSEcCtD
Clonazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.00294	0.00806	CbGpPWpGaD
Clonazepam—GABRG2—Orphan transporters—GABRA4—nicotine dependence	0.00292	0.00802	CbGpPWpGaD
Clonazepam—Depression—Varenicline—nicotine dependence	0.00287	0.00471	CcSEcCtD
Clonazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.00278	0.00764	CbGpPWpGaD
Clonazepam—GABRB2—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00276	0.00758	CbGpPWpGaD
Clonazepam—Flunitrazepam—GABRA4—nicotine dependence	0.00273	0.133	CrCbGaD
Clonazepam—Epistaxis—Varenicline—nicotine dependence	0.00272	0.00445	CcSEcCtD
Clonazepam—Sinusitis—Varenicline—nicotine dependence	0.0027	0.00443	CcSEcCtD
Clonazepam—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00264	0.00725	CbGpPWpGaD
Clonazepam—GABRA3—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00264	0.00723	CbGpPWpGaD
Clonazepam—GABRB2—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00262	0.00719	CbGpPWpGaD
Clonazepam—CYP2E1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00261	0.00715	CbGpPWpGaD
Clonazepam—Hallucination—Varenicline—nicotine dependence	0.00257	0.00421	CcSEcCtD
Clonazepam—Hypoaesthesia—Varenicline—nicotine dependence	0.00257	0.00421	CcSEcCtD
Clonazepam—GABRA1—Orphan transporters—GABRA4—nicotine dependence	0.00255	0.00701	CbGpPWpGaD
Clonazepam—Urinary tract disorder—Varenicline—nicotine dependence	0.00255	0.00418	CcSEcCtD
Clonazepam—Oedema peripheral—Varenicline—nicotine dependence	0.00255	0.00417	CcSEcCtD
Clonazepam—Connective tissue disorder—Varenicline—nicotine dependence	0.00254	0.00416	CcSEcCtD
Clonazepam—Urethral disorder—Varenicline—nicotine dependence	0.00253	0.00415	CcSEcCtD
Clonazepam—GABRG2—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00253	0.00693	CbGpPWpGaD
Clonazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.00252	0.00691	CbGpPWpGaD
Clonazepam—GABRA3—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.0025	0.00686	CbGpPWpGaD
Clonazepam—Visual impairment—Varenicline—nicotine dependence	0.00249	0.00408	CcSEcCtD
Clonazepam—Halazepam—GABRA4—nicotine dependence	0.00248	0.121	CrCbGaD
Clonazepam—Nitrazepam—GABRA4—nicotine dependence	0.00247	0.12	CrCbGaD
Clonazepam—Eye disorder—Varenicline—nicotine dependence	0.00242	0.00396	CcSEcCtD
Clonazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.00241	0.00663	CbGpPWpGaD
Clonazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.0024	0.00659	CbGpPWpGaD
Clonazepam—Cardiac disorder—Varenicline—nicotine dependence	0.0024	0.00393	CcSEcCtD
Clonazepam—GABRG2—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.0024	0.00657	CbGpPWpGaD
Clonazepam—Immune system disorder—Varenicline—nicotine dependence	0.00233	0.00383	CcSEcCtD
Clonazepam—Chills—Varenicline—nicotine dependence	0.00232	0.0038	CcSEcCtD
Clonazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.0023	0.00632	CbGpPWpGaD
Clonazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.0023	0.00632	CbGpPWpGaD
Clonazepam—Mental disorder—Varenicline—nicotine dependence	0.00226	0.00371	CcSEcCtD
Clonazepam—Malnutrition—Varenicline—nicotine dependence	0.00225	0.00369	CcSEcCtD
Clonazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.00224	0.00616	CbGpPWpGaD
Clonazepam—GABRB2—Ion channel transport—GABRA4—nicotine dependence	0.00224	0.00615	CbGpPWpGaD
Clonazepam—Flatulence—Varenicline—nicotine dependence	0.00222	0.00363	CcSEcCtD
Clonazepam—GABRA1—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00221	0.00606	CbGpPWpGaD
Clonazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.00221	0.00606	CbGpPWpGaD
Clonazepam—Flurazepam—GABRA4—nicotine dependence	0.00219	0.107	CrCbGaD
Clonazepam—Triazolam—GABRA4—nicotine dependence	0.00219	0.107	CrCbGaD
Clonazepam—Back pain—Varenicline—nicotine dependence	0.00218	0.00357	CcSEcCtD
Clonazepam—Muscle spasms—Varenicline—nicotine dependence	0.00216	0.00355	CcSEcCtD
Clonazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.00214	0.00588	CbGpPWpGaD
Clonazepam—CYP2E1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00214	0.00588	CbGpPWpGaD
Clonazepam—GABRA3—Ion channel transport—GABRA4—nicotine dependence	0.00214	0.00587	CbGpPWpGaD
Clonazepam—Oxazepam—GABRA4—nicotine dependence	0.00212	0.104	CrCbGaD
Clonazepam—Vision blurred—Varenicline—nicotine dependence	0.00212	0.00348	CcSEcCtD
Clonazepam—GABRB2—Neuronal System—CHRNB3—nicotine dependence	0.00212	0.00581	CbGpPWpGaD
Clonazepam—Tremor—Varenicline—nicotine dependence	0.00211	0.00345	CcSEcCtD
Clonazepam—GABRA1—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00209	0.00574	CbGpPWpGaD
Clonazepam—Ill-defined disorder—Varenicline—nicotine dependence	0.00209	0.00342	CcSEcCtD
Clonazepam—Anaemia—Varenicline—nicotine dependence	0.00208	0.00341	CcSEcCtD
Clonazepam—Agitation—Varenicline—nicotine dependence	0.00207	0.00339	CcSEcCtD
Clonazepam—Angioedema—Varenicline—nicotine dependence	0.00206	0.00337	CcSEcCtD
Clonazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.00205	0.00563	CbGpPWpGaD
Clonazepam—GABRG2—Ion channel transport—GABRA4—nicotine dependence	0.00205	0.00562	CbGpPWpGaD
Clonazepam—Midazolam—GABRA4—nicotine dependence	0.00203	0.0992	CrCbGaD
Clonazepam—Malaise—Varenicline—nicotine dependence	0.00203	0.00333	CcSEcCtD
Clonazepam—Vertigo—Varenicline—nicotine dependence	0.00202	0.00331	CcSEcCtD
Clonazepam—GABRA3—Neuronal System—CHRNB3—nicotine dependence	0.00202	0.00554	CbGpPWpGaD
Clonazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.00201	0.00553	CbGpPWpGaD
Clonazepam—GABRB2—Neuronal System—CHRNA6—nicotine dependence	0.00201	0.00551	CbGpPWpGaD
Clonazepam—Palpitations—Varenicline—nicotine dependence	0.00199	0.00326	CcSEcCtD
Clonazepam—Cough—Varenicline—nicotine dependence	0.00196	0.00322	CcSEcCtD
Clonazepam—GABRG2—Neuronal System—CHRNB3—nicotine dependence	0.00194	0.00531	CbGpPWpGaD
Clonazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.00193	0.0053	CbGpPWpGaD
Clonazepam—Arthralgia—Varenicline—nicotine dependence	0.00192	0.00314	CcSEcCtD
Clonazepam—Chest pain—Varenicline—nicotine dependence	0.00192	0.00314	CcSEcCtD
Clonazepam—Myalgia—Varenicline—nicotine dependence	0.00192	0.00314	CcSEcCtD
Clonazepam—GABRA3—Neuronal System—CHRNA6—nicotine dependence	0.00191	0.00525	CbGpPWpGaD
Clonazepam—Anxiety—Varenicline—nicotine dependence	0.00191	0.00313	CcSEcCtD
Clonazepam—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.0019	0.00312	CcSEcCtD
Clonazepam—GABRB2—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00189	0.0052	CbGpPWpGaD
Clonazepam—Discomfort—Varenicline—nicotine dependence	0.00189	0.0031	CcSEcCtD
Clonazepam—Dry mouth—Varenicline—nicotine dependence	0.00187	0.00307	CcSEcCtD
Clonazepam—Oedema—Varenicline—nicotine dependence	0.00184	0.00301	CcSEcCtD
Clonazepam—GABRG2—Neuronal System—CHRNA6—nicotine dependence	0.00184	0.00504	CbGpPWpGaD
Clonazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.00183	0.00502	CbGpPWpGaD
Clonazepam—Infection—Varenicline—nicotine dependence	0.00182	0.00299	CcSEcCtD
Clonazepam—GABRB2—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00182	0.00498	CbGpPWpGaD
Clonazepam—GABRA3—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00181	0.00496	CbGpPWpGaD
Clonazepam—Nervous system disorder—Varenicline—nicotine dependence	0.0018	0.00295	CcSEcCtD
Clonazepam—Thrombocytopenia—Varenicline—nicotine dependence	0.0018	0.00295	CcSEcCtD
Clonazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.00179	0.00492	CbGpPWpGaD
Clonazepam—Tachycardia—Varenicline—nicotine dependence	0.00179	0.00294	CcSEcCtD
Clonazepam—GABRA1—Ion channel transport—GABRA4—nicotine dependence	0.00179	0.00492	CbGpPWpGaD
Clonazepam—Skin disorder—Varenicline—nicotine dependence	0.00178	0.00292	CcSEcCtD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00177	0.00486	CbGpPWpGaD
Clonazepam—Anorexia—Varenicline—nicotine dependence	0.00175	0.00287	CcSEcCtD
Clonazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.00175	0.00479	CbGpPWpGaD
Clonazepam—GABRG2—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00173	0.00475	CbGpPWpGaD
Clonazepam—GABRA3—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00173	0.00475	CbGpPWpGaD
Clonazepam—Hypotension—Varenicline—nicotine dependence	0.00172	0.00281	CcSEcCtD
Clonazepam—GABRA1—Neuronal System—CHRNB3—nicotine dependence	0.00169	0.00464	CbGpPWpGaD
Clonazepam—GABRB2—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00169	0.00463	CbGpPWpGaD
Clonazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.00167	0.00459	CbGpPWpGaD
Clonazepam—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00167	0.00274	CcSEcCtD
Clonazepam—Insomnia—Varenicline—nicotine dependence	0.00166	0.00272	CcSEcCtD
Clonazepam—GABRG2—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00166	0.00456	CbGpPWpGaD
Clonazepam—Dyspnoea—Varenicline—nicotine dependence	0.00164	0.00268	CcSEcCtD
Clonazepam—Somnolence—Varenicline—nicotine dependence	0.00163	0.00268	CcSEcCtD
Clonazepam—Dyspepsia—Varenicline—nicotine dependence	0.00162	0.00265	CcSEcCtD
Clonazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.00161	0.00442	CbGpPWpGaD
Clonazepam—GABRA3—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00161	0.00442	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—CHRNA6—nicotine dependence	0.0016	0.0044	CbGpPWpGaD
Clonazepam—Decreased appetite—Varenicline—nicotine dependence	0.0016	0.00262	CcSEcCtD
Clonazepam—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00159	0.0026	CcSEcCtD
Clonazepam—Fatigue—Varenicline—nicotine dependence	0.00158	0.00259	CcSEcCtD
Clonazepam—Pain—Varenicline—nicotine dependence	0.00157	0.00257	CcSEcCtD
Clonazepam—Constipation—Varenicline—nicotine dependence	0.00157	0.00257	CcSEcCtD
Clonazepam—GABRG2—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00154	0.00424	CbGpPWpGaD
Clonazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.00154	0.00422	CbGpPWpGaD
Clonazepam—GABRA1—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00151	0.00415	CbGpPWpGaD
Clonazepam—Feeling abnormal—Varenicline—nicotine dependence	0.00151	0.00248	CcSEcCtD
Clonazepam—Gastrointestinal pain—Varenicline—nicotine dependence	0.0015	0.00246	CcSEcCtD
Clonazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.00147	0.00404	CbGpPWpGaD
Clonazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.00146	0.00401	CbGpPWpGaD
Clonazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.00146	0.00401	CbGpPWpGaD
Clonazepam—Urticaria—Varenicline—nicotine dependence	0.00146	0.00239	CcSEcCtD
Clonazepam—Abdominal pain—Varenicline—nicotine dependence	0.00145	0.00238	CcSEcCtD
Clonazepam—Body temperature increased—Varenicline—nicotine dependence	0.00145	0.00238	CcSEcCtD
Clonazepam—GABRA1—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00145	0.00398	CbGpPWpGaD
Clonazepam—GABRB2—Neuronal System—GABRA4—nicotine dependence	0.00145	0.00398	CbGpPWpGaD
Clonazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.0014	0.00383	CbGpPWpGaD
Clonazepam—GABRB2—Neuronal System—CHRNB4—nicotine dependence	0.00139	0.00382	CbGpPWpGaD
Clonazepam—GABRA3—Neuronal System—GABRA4—nicotine dependence	0.00138	0.0038	CbGpPWpGaD
Clonazepam—GABRB2—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00138	0.00378	CbGpPWpGaD
Clonazepam—Hypersensitivity—Varenicline—nicotine dependence	0.00135	0.00222	CcSEcCtD
Clonazepam—GABRA1—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00135	0.0037	CbGpPWpGaD
Clonazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.00134	0.00367	CbGpPWpGaD
Clonazepam—GABRA3—Neuronal System—CHRNB4—nicotine dependence	0.00133	0.00364	CbGpPWpGaD
Clonazepam—GABRG2—Neuronal System—GABRA4—nicotine dependence	0.00133	0.00364	CbGpPWpGaD
Clonazepam—Asthenia—Varenicline—nicotine dependence	0.00132	0.00216	CcSEcCtD
Clonazepam—GABRA3—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00131	0.0036	CbGpPWpGaD
Clonazepam—Pruritus—Varenicline—nicotine dependence	0.0013	0.00213	CcSEcCtD
Clonazepam—GABRB2—Neuronal System—CHRNA5—nicotine dependence	0.00129	0.00355	CbGpPWpGaD
Clonazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.00129	0.00353	CbGpPWpGaD
Clonazepam—GABRG2—Neuronal System—CHRNB4—nicotine dependence	0.00127	0.00349	CbGpPWpGaD
Clonazepam—GABRG2—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00126	0.00345	CbGpPWpGaD
Clonazepam—Diarrhoea—Varenicline—nicotine dependence	0.00126	0.00206	CcSEcCtD
Clonazepam—GABRA3—Neuronal System—CHRNA5—nicotine dependence	0.00123	0.00338	CbGpPWpGaD
Clonazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00123	0.00336	CbGpPWpGaD
Clonazepam—Dizziness—Varenicline—nicotine dependence	0.00121	0.00199	CcSEcCtD
Clonazepam—GABRB2—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00121	0.00332	CbGpPWpGaD
Clonazepam—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00121	0.00332	CbGpPWpGaD
Clonazepam—CYP2E1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00121	0.00331	CbGpPWpGaD
Clonazepam—GABRG2—Neuronal System—CHRNA5—nicotine dependence	0.00118	0.00325	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00118	0.00324	CbGpPWpGaD
Clonazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.00117	0.00321	CbGpPWpGaD
Clonazepam—Vomiting—Varenicline—nicotine dependence	0.00117	0.00191	CcSEcCtD
Clonazepam—GABRA1—Neuronal System—GABRA4—nicotine dependence	0.00116	0.00318	CbGpPWpGaD
Clonazepam—Rash—Varenicline—nicotine dependence	0.00116	0.0019	CcSEcCtD
Clonazepam—Dermatitis—Varenicline—nicotine dependence	0.00116	0.0019	CcSEcCtD
Clonazepam—GABRA3—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00116	0.00317	CbGpPWpGaD
Clonazepam—Headache—Varenicline—nicotine dependence	0.00115	0.00189	CcSEcCtD
Clonazepam—CYP2E1—Biological oxidations—CYP2A7—nicotine dependence	0.00114	0.00312	CbGpPWpGaD
Clonazepam—CYP2E1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00112	0.00308	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—CHRNB4—nicotine dependence	0.00111	0.00305	CbGpPWpGaD
Clonazepam—GABRG2—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00111	0.00304	CbGpPWpGaD
Clonazepam—GABRB2—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.0011	0.00302	CbGpPWpGaD
Clonazepam—GABRA1—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.0011	0.00302	CbGpPWpGaD
Clonazepam—Nausea—Varenicline—nicotine dependence	0.00109	0.00179	CcSEcCtD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00107	0.00294	CbGpPWpGaD
Clonazepam—GABRB2—Neuronal System—CHRNA3—nicotine dependence	0.00105	0.00289	CbGpPWpGaD
Clonazepam—GABRA3—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00105	0.00288	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—CHRNA5—nicotine dependence	0.00103	0.00284	CbGpPWpGaD
Clonazepam—GABRG2—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00101	0.00276	CbGpPWpGaD
Clonazepam—GABRA3—Neuronal System—CHRNA3—nicotine dependence	0.00101	0.00276	CbGpPWpGaD
Clonazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000993	0.00273	CbGpPWpGaD
Clonazepam—GABRA1—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000968	0.00266	CbGpPWpGaD
Clonazepam—GABRG2—Neuronal System—CHRNA3—nicotine dependence	0.000964	0.00265	CbGpPWpGaD
Clonazepam—GABRB2—Neuronal System—CHRNB2—nicotine dependence	0.000928	0.00255	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—CYP2A7—nicotine dependence	0.000918	0.00252	CbGpPWpGaD
Clonazepam—GABRA3—Neuronal System—CHRNB2—nicotine dependence	0.000885	0.00243	CbGpPWpGaD
Clonazepam—GABRA1—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000879	0.00241	CbGpPWpGaD
Clonazepam—GABRG2—Neuronal System—CHRNB2—nicotine dependence	0.000849	0.00233	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—CHRNA3—nicotine dependence	0.000843	0.00231	CbGpPWpGaD
Clonazepam—GABRB2—Neuronal System—CHRNA4—nicotine dependence	0.000843	0.00231	CbGpPWpGaD
Clonazepam—GABRA3—Neuronal System—CHRNA4—nicotine dependence	0.000804	0.00221	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00078	0.00214	CbGpPWpGaD
Clonazepam—GABRG2—Neuronal System—CHRNA4—nicotine dependence	0.000771	0.00211	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000744	0.00204	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—CHRNB2—nicotine dependence	0.000742	0.00204	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000713	0.00196	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—CHRNA4—nicotine dependence	0.000674	0.00185	CbGpPWpGaD
Clonazepam—Clozapine—DRD2—nicotine dependence	0.000647	0.0316	CrCbGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000623	0.00171	CbGpPWpGaD
Clonazepam—TSPO—cardiovascular system—nicotine dependence	0.000563	0.115	CbGeAlD
Clonazepam—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00056	0.00154	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000528	0.00145	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00052	0.00143	CbGpPWpGaD
Clonazepam—GABRG2—midbrain—nicotine dependence	0.00052	0.107	CbGeAlD
Clonazepam—GABRB2—midbrain—nicotine dependence	0.00052	0.107	CbGeAlD
Clonazepam—GABRA1—midbrain—nicotine dependence	0.000459	0.0941	CbGeAlD
Clonazepam—TSPO—midbrain—nicotine dependence	0.000439	0.0902	CbGeAlD
Clonazepam—GABRA3—brain—nicotine dependence	0.0004	0.0822	CbGeAlD
Clonazepam—ALB—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000357	0.000979	CbGpPWpGaD
Clonazepam—GABRB2—brain—nicotine dependence	0.000326	0.067	CbGeAlD
Clonazepam—GABRG2—brain—nicotine dependence	0.000326	0.067	CbGeAlD
Clonazepam—CYP2E1—cardiovascular system—nicotine dependence	0.000325	0.0667	CbGeAlD
Clonazepam—GABRA1—brain—nicotine dependence	0.000288	0.0592	CbGeAlD
Clonazepam—TSPO—brain—nicotine dependence	0.000276	0.0567	CbGeAlD
Clonazepam—ALB—brain—nicotine dependence	0.00027	0.0553	CbGeAlD
Clonazepam—CYP2E1—Metabolism—CYP2A7—nicotine dependence	0.000195	0.000534	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CYP2A7—nicotine dependence	0.000167	0.000459	CbGpPWpGaD
Clonazepam—CYP2E1—brain—nicotine dependence	0.00016	0.0327	CbGeAlD
Clonazepam—CYP3A4—Metabolism—CYP2A7—nicotine dependence	9.02e-05	0.000248	CbGpPWpGaD
